Medical devices refer to instruments, machines or appliances essential to the delivery of healthcare and designed for diagnosis, monitoring, cure or prevention of any disease or for some other specific medical purposes. The medical devices market can be classified into the following segments: general medical, orthopedic, cardiovascular, respiratory, home healthcare, surgical devices, etc.
North America has the competitive advantage on the market, accounting for the market share of above 45%. Technological advancements in medicine, introduction of new treatment modes, product innovations, expansion of the medical facilities infrastructure, rising health awareness, growing population and the increasing number of elderly people are the key drivers of the global medical devices market. Abbott Labs, Johnson & Johnson, Baxter, Medtronic, Becton Dickinson, Boston Scientific, Stryker Corporation, GE Healthcare Technologies and Beckman Coulter are amid the most recognized participants of the industry.
The catalogue encompasses a wealthy collection of research reports providing extensive analyses of the medical devices market at all geographical levels possible. The researches present the essential findings on the market dynamics, identify the main market barriers and opportunities. The reports also evaluate the market competition and point out top market players. Besides, the future forecasts for the market are revealed in the research reports.
Publications found:
34,013
Sort by:
North America Diabetes Devices Market - 2024-2033
US$ 2,999.00
The North America Diabetes Devices Market was valued at US$ 13.76 Billion in 2024 and is anticipated to reach US$ 28.50 Billion by 2033, at a CAGR of 0.075 from 2026 to 2032. The report delivers in-de...
January 2026
219 pages
Intravenous Hydration Therapy Market Size, Share & Trends Analysis Report By Service (Immune Boosters, Energy Boosters), By Component (Medicated, Non-medicated), By Provider (Mobile, Physical), By End-use, By Region, And Segment Forecasts, 2026 - 2033
US$ 5,950.00
The global intravenous hydration therapy market size was valued at USD 2.83 billion in 2025 and is projected to reach USD 5.66 billion by 2033, growing at a CAGR of 9.2% from 2026 to 2033. This growth...
January 2026
190 pages
Injectable Drug Delivery Market Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Device Type [Conventional Drug Delivery Devices and Advanced Drug Delivery Devices (Prefilled Syringes, Pen Injectors, Autoinjectors, Needle-Free Injectors, Wearable Injectors, and Other Advanced Types)], Formulation [Conventional Drug Delivery (Solutions, Reconstituted/ Lyophilized formulations, Suspensions, and Emulsions), Novel Drug Delivery (Colloidal Dispersion, Microparticles, Other Novel Drug Delivery), Long Acting Injectable Formulations], Formulation Packaging (Ampoules, Vials, Cartridges, Bottles), Therapeutic Application (Diabetes, Oncology, Autoimmune Disorders, Cardiovascular Diseases, Infectious Diseases, Pain Management, and Other Therapeutic Application), Usability (Disposable Injectors, Reusable Injectors), Route of Administration (Sub-cutaneous, Intramuscular, Intravenous, and Other Route of Administration), End User (Pharmaceutical and Biopharma Companies, CMOs, and CDMOs), and Geography (North America, Europe, Asia Pacific, Middle East and Africa, and South and Central America)
US$ 4,450.00
According to our new research study on “Injectable Drug Delivery Market Forecast to 2031 –Global Analysis – by Type, and End User,” the market is anticipated to grow from US$ 40.56 billion in 2024 to...
January 2026
476 pages
